CATALYST PHARMACEUTICALS INC's ticker is and the CUSIP is 14888U951. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | -90.3% | 1,600 | -88.4% | 0.00% | – |
| Q2 2023 | $185 | +77.9% | 13,800 | +119.0% | 0.00% | – |
| Q1 2023 | $104 | +6.1% | 6,300 | +18.9% | 0.00% | – |
| Q4 2022 | $98 | -100.0% | 5,300 | -82.6% | 0.00% | – |
| Q3 2022 | $390,000 | +5471.4% | 30,400 | +2663.6% | 0.00% | – |
| Q2 2022 | $7,000 | -97.5% | 1,100 | -96.8% | 0.00% | – |
| Q1 2022 | $281,000 | +5520.0% | 34,000 | +4150.0% | 0.00% | – |
| Q4 2021 | $5,000 | -99.0% | 800 | -99.0% | 0.00% | – |
| Q3 2021 | $487,000 | +0.6% | 84,200 | 0.0% | 0.00% | – |
| Q2 2021 | $484,000 | +680.6% | 84,200 | +62270.4% | 0.00% | – |
| Q1 2021 | $62,000 | +12.7% | 135 | -18.7% | 0.00% | – |
| Q4 2020 | $55,000 | +71.9% | 166 | +53.7% | 0.00% | – |
| Q3 2020 | $32,000 | -47.5% | 108 | -18.8% | 0.00% | – |
| Q2 2020 | $61,000 | +52.5% | 133 | +27.9% | 0.00% | – |
| Q1 2020 | $40,000 | +8.1% | 104 | +5.1% | 0.00% | – |
| Q4 2019 | $37,000 | -75.2% | 99 | -64.9% | 0.00% | – |
| Q3 2019 | $149,000 | -21.2% | 282 | -42.8% | 0.00% | -100.0% |
| Q2 2019 | $189,000 | -26.7% | 493 | -2.6% | 0.00% | 0.0% |
| Q1 2019 | $258,000 | +25700.0% | 506 | +12550.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 13,200 | $169,000 | 0.00% |
| SIMPLEX TRADING, LLC | 30,400 | $390,000 | 0.00% |
| JANE STREET GROUP, LLC | 68,800 | $883,000 | 0.00% |